Introduction
Oxidative stress can be underlying reason for many neurodegenerative diseases, such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, inflammatory diseases, rheumatoid arthritis, cardiovascular disease, and muscular dystrophy, etc. It is also causes allergies, immune system disorders, diabetes, aging and various types of cancer. For example, inflammatory cells release chemical mediators of inflammation, particularly ROS, in tissue; when this occurs, the extremely high ROS levels cause cell damage and block the cell defense mechanisms (e.g. antioxidants) and inhibit detoxification [1] .
Due to importance of oxidative balance, this study aims to reveal the relation between the serum MDA, GSH, SOD and CAT activities and neoplasia in patients with ovarian neoplasia.
Materials and Methods
The case group of this study was consisted of 35 ovarian cancer diagnosed patients, who were admitted to the gynecology wards of Dursun Determination of MDA Levels: 0.8 ml of phosphate buffer, 0.025 ml of BHT and 0.5 ml of 30% TCA were added on 0.2 ml of serum. The tubes were vortex mixed and incubated in ice for 2 hours. They were then centrifuged at 2.000 rpm for 15 minutes. 1 ml of supernatant was taken into another tube. Then, 0.075 ml of 0.1 M EDTA and 0.025 ml of 1% TBA were added. The tubes are mixed and incubated in boiling water bath for 15 minutes. After being cooled down to the room temperature, absorbance was spectrophotometrically measured at 532 nm in Hitachi U-2900 originated from Tokyo-Japan [2] .
Determination of SOD Activities:
The enzyme was spectrophotometrically measured (AtiUnicam UV/VIS-UV2-100, England) using commercial kits of the brand Randox (Randox: 55 Diamond Road, Crumlin, Co. Antrim, United Kingdom, BT29 4QY) and absorbance values were read in Hitachi U-2900 [3] .
Determination of GSH Activities: 0.8 ml of phosphate buffer was added in each tube containing 0.2 ml of serum and the GSH activities were measured at 412 nm. Then, 0.1 ml of DTNB was added and optical density was read at 412 nm in Hitachi U-2900 [4] .
Determination of Catalase Activities:
One blank tube and one sample tube were obtained for determination of catalase activity. 2.8 ml of 30 mM H 2 O 2 was put into the blank tube and 0.2 ml of phosphate buffer was added. The mixture was shaken swiftly and spectrophotometrically measured (Ati Unicam UV/VIS-UV2-100,England) twice at 240 nm with 30 second intervals [5] Statistical analysis: The data were presented as average ± standard deviation (SD). The data were compared between the groups for continuous variables and chi-square with Student T test using an SPSS 16.0 data set (SPSS Inc, Chicago , IL , USA). Student T test was used for variable without normal distribution. P -value< 0.05 was considered meaningful.
Results
Serum reduced glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) activities and serum melondialdehyde (MDA) levels were determined spectrophotometrically. Superoxide dismutase (SOD), catalase (CAT) and serum reduced glutathione (GSH) activities were found to be lower than the healthy control group. The differences were considered statistically meaningful (p:0.001).When the patient group was evaluated in itself, preoperative superoxide dismutase (SOD) and serum reduced glutathione (GSH) activities were found to be higher than the postoperative values. As for the catalase (CAT) activity, preoperative values were found to be lower than the postoperative values. Serum malondialdehyde (MDA) levels were higher in the patient group. The differences were considered statistically meaningful (p:0.001). When the patient group was evaluated in itself, preoperative serum malondialdehyde (MDA) levels were found to be higher than the postoperative values (Table 1) .
Discussion
Reactive oxygen species (ROS) can be result of dysbalance between the production of free radicals and antioxidant system which plays a role inthe pathogenesis of fatal diseases such as cancer and cardiovascular diseases [6] . Free radicals are implicated that immune system, digestive system, heart, lungs, muscle-related diseases with aging, atherosclerosis, cancer, diabetes, rheumatoid arthritis in many pathological conditions [7] .
In these pathological conditions, when catalase, glutathione, glutathione peroxidase, superoxide dismutase prevents, the cell enzyme functions are also fully maintains. Antioxidant enzymatic activity of the cells is sufficient resistance to oncogenic substances increases. Enzymes such as catalase, glutathione, glutathione peroxidase and superoxide dismutase enzymes are protected from necrotic degradation of organism [7] . Antioxidants inhibit the activities of free radicals and play a preventive role in tumor-related processes. Many synthetic and natural antioxidants have a positive effect on human health and they are also considered to prevent some diseases [8] . For this reason, the functions of antioxidants are important for preventing the formation of free radicals or breaking the chains. It was shown that antioxidants neutralize free radicals and prevent cell damage [9] . There are some contradictory studies in literature regarding antioxidant activities in patients with cancer. SOD activity in esophageal cancer patients have been found lower than those in healthy people [10] . Serum SOD activities were found to be lower in patients with ovarian cancer compared to the healthy control group (Table 1) . This finding should be evaluated in wide scale studies.
MDA level in esophageal cancer patients have been found higher than those in healthy people [10] . Meaningfully high serum MDA levels were found in patients with ovarian cancer (Table 1) . In literature, glutation activity has been found significantly lower in patients with esophageal squamous cell carcinoma than in controls. In this study, the serum GSH activity was observed to decrease in patients with ovarian cancer. In the literature, catalase enzyme activity is usually reduced in esophageal squamous cell carcinoma [10] .
The serum CAT activity was found significantly lower in patients with ovarian cancer than controls ( p<0.05).
Conclusion
Some studies found higher GSH levels in primary and metastatic ovarian malignancies, than found in benign ovarian tumor samples or normal ovarian tissue. Differently from the literature, our study found higher serum reduced glutathione (GSH) levels in the healthy control group compared to the patient group with ovarian neoplasia [11, 12] .
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